Fredrik Rågmark

Board Director

Director

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 1 saleSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€2.1M

Latest filing published 12 Aug 2026 for Medicover AB, €2.1M. Read the official filing

Filing timeline

BuySale

Fredrik Rågmark

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Fredrik Rågmark: trading record in brief

This profile gathers the share dealings of Fredrik Rågmark in Medicover AB, where the filings describe the role as board member. Between 7 May 2026 and 10 August 2026, the trades on record add up to 3 filings.

No open-market purchase appears, only 1 sale worth €2.1M. Outside the open market, there are 2 share grants.

Most recently, on 12 August 2026, the filings show an open-market sale worth €2.1M in Medicover AB. The median gap between a trade and its publication by Finansinspektionen is 4 days. For comparison, MAR article 19 gives managers three business days to notify a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.